PCRI's resident moderator, Mark Moyad, MD, MPH, asks Dr. Mark Scholz about his experience "semaglutide," a medication used to facilitate weight loss. He asks if it is really the game-changer it is hyped up to be and how it compares to other weight loss medications that have been used in the past and presently.
To view the full presentation and Q&A, watch a replay of our Virtual Men's Health Fair here: [ Ссылка ]
Don’t know your stage? Take the quiz: Visit [ Ссылка ]
To learn more about prostate cancer visit [ Ссылка ]
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: [ Ссылка ]
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#wegovy #MarkScholzMD #ozempic
